ALCAM and multiple sclerosis: Furthermore, activated leukocyte cell adhesion molecule (ALCAM), a biologically validated target of miR-126* in HUVEC29, has been shown to be upregulated in neuroinflammation (multiple sclerosis lesions) and mediates leukocyte migration into the CNS, in particular CD14+ monocytes63.